Richard Anthony Cunningham - Oct 6, 2023 Form 4 Insider Report for Anebulo Pharmaceuticals, Inc. (ANEB)

Role
Chief Executive Officer, Director
Signature
/s/ Daniel George, Attorney-in-Fact
Stock symbol
ANEB
Transactions as of
Oct 6, 2023
Transactions value $
$0
Form type
4
Date filed
10/11/2023, 05:25 PM
Previous filing
Sep 16, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANEB Stock Option (right to buy) Award $0 +600K $0.00 600K Oct 6, 2023 Common Stock 600K $3.03 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option will vest and become exercisable as follows: ratably in 16 quarterly installments (37,500 per installment) on the first day of each calendar quarter commencing with January 1, 2024, such that option will be full vested on October 1, 2027.